MERIDIAN BIOSCIENCE, INC. Proceeds from Stock Options Exercised
MERIDIAN BIOSCIENCE, INC. reported Proceeds from Stock Options Exercised of $799.00 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-02-09
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was $799.00K, a 898.75% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2022-09-30 was $12.00K, a 89.38% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2022-06-30 was $1.70M, a 1857.47% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2022-03-31 was $655.00K.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for fiscal 2022 was $2.45M, a 19.72% decline from fiscal 2021.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for fiscal 2021 was $3.05M, a 14.25% decline from fiscal 2020.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for fiscal 2020 was $3.56M, a 703.39% increase from fiscal 2019.
- MERIDIAN BIOSCIENCE, INC. proceeds from stock options exercised for fiscal 2019 was $443.00K, a 142.08% increase from fiscal 2018.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | $799.00K 10-Q · filed 2023-02-09 | $811.00K derived: sum of 2 quarters · filed 2023-02-09 | $2.51M derived: sum of 3 quarters · filed 2023-02-09 | $3.17M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-09-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $1.72M derived: sum of 2 quarters · filed 2022-11-22 | $2.37M derived: sum of 3 quarters · filed 2022-11-22 | $2.45M 10-K · filed 2022-11-22 |
| 2022-06-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-05 | $2.36M derived: sum of 2 quarters · filed 2022-08-05 | $2.44M 10-Q · filed 2022-08-05 | $2.55M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-03-31 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-06 | $735.00K 10-Q · filed 2022-05-06 | $848.00K derived: sum of 3 quarters · filed 2023-02-09 | $935.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-12-31 | $80.00K 10-Q · filed 2023-02-09 | $193.00K derived: sum of 2 quarters · filed 2023-02-09 | $280.00K derived: sum of 3 quarters · filed 2023-02-09 | |
| 2021-09-30 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $200.00K derived: sum of 2 quarters · filed 2022-11-22 | $3.05M 10-K · filed 2022-11-22 | |
| 2021-06-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-05 | $2.94M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $2.85M 10-Q · filed 2022-05-06 | |||
| 2020-09-30 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $3.56M 10-K · filed 2022-11-22 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $0.00 derived: sum of 2 quarters · filed 2021-11-23 | $377.00K derived: sum of 3 quarters · filed 2021-11-23 | $443.00K 10-K · filed 2021-11-23 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-07 | $377.00K derived: sum of 2 quarters · filed 2020-08-07 | $443.00K 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $377.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-08 | $443.00K 10-Q · filed 2020-05-08 | ||
| 2018-12-31 | $66.00K 10-Q · filed 2020-02-07 | |||
| 2018-09-30 | $183.00K 10-K · filed 2020-11-23 | |||
| 2017-09-30 | $302.00K 10-K · filed 2019-11-26 | |||
| 2016-09-30 | $2.36M 10-K · filed 2018-11-29 | |||
| 2015-09-30 | $2.48M 10-K · filed 2017-11-29 |